These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15110844)

  • 1. Clozapine derived 2,3-dihydro-1H-1,4- and 1,5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing.
    Hussenether T; Hübner H; Gmeiner P; Troschütz R
    Bioorg Med Chem; 2004 May; 12(10):2625-37. PubMed ID: 15110844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles.
    Schlotter K; Boeckler F; Hübner H; Gmeiner P
    J Med Chem; 2005 Jun; 48(11):3696-9. PubMed ID: 15916420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents.
    Unangst PC; Capiris T; Connor DT; Doubleday R; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
    J Med Chem; 1997 Dec; 40(25):4026-9. PubMed ID: 9406594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
    Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.
    Linz S; Müller J; Hübner H; Gmeiner P; Troschütz R
    Bioorg Med Chem; 2009 Jul; 17(13):4448-58. PubMed ID: 19481941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
    Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists.
    Woltering TJ; Wichmann J; Goetschi E; Adam G; Kew JN; Knoflach F; Ballard TM; Huwyler J; Mutel V; Gatti S
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2725-9. PubMed ID: 18374569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of fluorine-substituted 1H-pyrrolo[2,3-b]pyridine derivatives for dopamine D4 receptor imaging.
    Oh SJ; Lee KC; Lee SY; Ryu EK; Saji H; Choe YS; Chi DY; Kim SE; Lee J; Kim BT
    Bioorg Med Chem; 2004 Nov; 12(21):5505-13. PubMed ID: 15465327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
    Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis.
    Hamacher A; Weigt M; Wiese M; Hoefgen B; Lehmann J; Kassack MU
    BMC Pharmacol; 2006 Sep; 6():11. PubMed ID: 16978403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.
    Frantz MC; Rodrigo J; Boudier L; Durroux T; Mouillac B; Hibert M
    J Med Chem; 2010 Feb; 53(4):1546-62. PubMed ID: 20104850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
    Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
    Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological investigations of dopaminergic partial agonists preferentially recognizing the D4 receptor subtype.
    Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2955-9. PubMed ID: 16563764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
    Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
    Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
    Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.